Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2015 | Research article

Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza

Authors: John H. Powers, M. Lourdes Guerrero, Nancy Kline Leidy, Mary P. Fairchok, Alice Rosenberg, Andrés Hernández, Sonja Stringer, Christina Schofield, Patricia Rodríguez-Zulueta, Katherine Kim, Patrick J. Danaher, Hilda Ortega-Gallegos, Elizabeth Dansie Bacci, Nathaniel Stepp, Arturo Galindo-Fraga, Kristina St. Clair, Michael Rajnik, Erin A. McDonough, Michelande Ridoré, John C. Arnold, Eugene V. Millar, Guillermo M. Ruiz-Palacios

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

To develop content validity of a comprehensive patient-reported outcome (PRO) measure following current best scientific methodology to standardize assessment of influenza (flu) symptoms in clinical research.

Methods

Stage I (Concept Elicitation): 1:1 telephone interviews with influenza-positive adults (≥18 years) in the US and Mexico within 7 days of diagnosis. Participants described symptom type, character, severity, and duration. Content analysis identified themes and developed the draft Flu-PRO instrument. Stage II (Cognitive Interviewing): The Flu-PRO was administered to a unique set of influenza-positive adults within 14 days of diagnosis; telephone interviews addressed completeness, respondent interpretation of items and ease of use.

Results

Samples: Stage I: N = 46 adults (16 US, 30 Mexico); mean (SD) age: 38 (19), 39 (14) years; % female: 56 %, 73 %; race: 69 % White, 97 % Mestizo. Stage II: N = 34 adults (12 US, 22 Mexico); age: 37 (14), 39 (11) years; % female: 50 %, 50 %; race: 58 % White, 100 % Mestizo. Symptoms: Symptoms identified by >50 %: coughing, weak or tired, throat symptoms, congestion, headache, weakness, sweating, chills, general discomfort, runny nose, chest (trouble breathing), difficulty sleeping, and body aches or pains. No new content was uncovered during Stage II; participants easily understood the instrument.

Conclusions

Results show the 37-item Flu-PRO is a content valid measure of influenza symptoms in adults with a confirmed diagnosis of influenza. Research is underway to evaluate the suitability of the instrument for children and adolescents. This work can form the basis for future quantitative tests of reliability, validity, and responsiveness to evaluate the measurement properties of Flu-PRO for use in clinical trials and epidemiology studies.
Literature
6.
go back to reference Food and Drug Administration. Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. Fed Regis. 2009;74:65132–3. Food and Drug Administration. Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. Fed Regis. 2009;74:65132–3.
7.
go back to reference Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding. Value Health. 2011;14:978–88.PubMedCrossRef Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding. Value Health. 2011;14:978–88.PubMedCrossRef
8.
go back to reference Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument. Value Health. 2011;14:967–77.PubMedCrossRef Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument. Value Health. 2011;14:967–77.PubMedCrossRef
9.
go back to reference Leidy NK, Vernon M. Perspectives on patient-reported outcomes: content validity and qualitative research in a changing clinical trial environment. Pharmacoeconomics. 2008;26:363–70.PubMedCrossRef Leidy NK, Vernon M. Perspectives on patient-reported outcomes: content validity and qualitative research in a changing clinical trial environment. Pharmacoeconomics. 2008;26:363–70.PubMedCrossRef
10.
go back to reference Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8:94–104.PubMedCrossRef Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8:94–104.PubMedCrossRef
11.
go back to reference Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, et al. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health. 2009;12:419–29.PubMedCrossRef Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, et al. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health. 2009;12:419–29.PubMedCrossRef
12.
go back to reference Osborne R, Hawthorne G, Papanicolaou M, Wegmueller Y. Measurement of rapid changes in health outcomes in people with influenza symptoms. J Outcomes Res. 2000;4:15–30. Osborne R, Hawthorne G, Papanicolaou M, Wegmueller Y. Measurement of rapid changes in health outcomes in people with influenza symptoms. J Outcomes Res. 2000;4:15–30.
13.
go back to reference Osborne RH, Norquist JM, Elsworth GR, Busija L, Mehta V, Herring T, et al. Development and validation of the Influenza Intensity and Impact Questionnaire (FluiiQ). Value Health. 2011;14:687–99.PubMedCrossRef Osborne RH, Norquist JM, Elsworth GR, Busija L, Mehta V, Herring T, et al. Development and validation of the Influenza Intensity and Impact Questionnaire (FluiiQ). Value Health. 2011;14:687–99.PubMedCrossRef
14.
go back to reference Ames NJ, Peng C, Powers JH, Leidy NK, Miller-Davis C, Rosenberg A, et al. Beyond intuition: patient fever symptom experience. J Pain Symptom Manage. 2013;46:807–16.PubMedCrossRef Ames NJ, Peng C, Powers JH, Leidy NK, Miller-Davis C, Rosenberg A, et al. Beyond intuition: patient fever symptom experience. J Pain Symptom Manage. 2013;46:807–16.PubMedCrossRef
Metadata
Title
Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza
Authors
John H. Powers
M. Lourdes Guerrero
Nancy Kline Leidy
Mary P. Fairchok
Alice Rosenberg
Andrés Hernández
Sonja Stringer
Christina Schofield
Patricia Rodríguez-Zulueta
Katherine Kim
Patrick J. Danaher
Hilda Ortega-Gallegos
Elizabeth Dansie Bacci
Nathaniel Stepp
Arturo Galindo-Fraga
Kristina St. Clair
Michael Rajnik
Erin A. McDonough
Michelande Ridoré
John C. Arnold
Eugene V. Millar
Guillermo M. Ruiz-Palacios
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-1330-0

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue